drugset / Trial / NCT00529191
Atorvastatin in New Onset Type 1 Diabetes Mellitus (T1DM)
Phase 2
Completed
40 enrolled
Children's Hospital of Philadelphia
FDA Office of Orphan Products Development · collabMedical University of South Carolina · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The goal of this application is to evaluate the safety and efficacy of atorvastatin as a potential treatment to preserve beta cell function in children and young adults with newly diagnosed type 1 diabetes (T1DM).
Timeline
- Start
- 2007-07
- Primary completion
- 2011-07
- Completion
- 2013-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atorvastatin | Small molecule | 20 mg | Oral |